BBHC
TTOO

Brown Brothers Harriman & Co’s T2 Biosystems, Inc TTOO Stock Holding History

Brown Brothers Harriman & Co’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1
Closed -$27K – 1175
2017
Q4 		$27K Buy
+1
New +$20.6K ﹤0.01% 603

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SH
Sandia Holdings Greenwich, Connecticut $213M AUM 29.35% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Brown Brothers Harriman & Co's TTOO Position: Q1 2018 in Review

Brown Brothers Harriman & Co sold out of T2 Biosystems, Inc (TTOO) in Q1 2018, closing a stake of 1 share — an estimated $27K sold.

Brown Brothers Harriman & Co first reported a position in TTOO in Q4 2017 and held it in 1 quarter. The position peaked at $27K in Q4 2017. 45 funds tracked by Wall St. Rank hold TTOO as of Q1 2018.

  • Brown Brothers Harriman & Co reported no remaining T2 Biosystems, Inc position as of Q1 2018 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 1 T2 Biosystems, Inc share in Q1 2018, an estimated $27K.
  • Brown Brothers Harriman & Co first reported a position in T2 Biosystems, Inc in Q4 2017 and held it in 1 quarter.
  • Brown Brothers Harriman & Co's T2 Biosystems, Inc position peaked at $27K in Q4 2017.
  • 45 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2018.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2018, filed 14 May 2018.